Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07122427

Aging of the Vascular Wall

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death, becomes more prevalent with age. Aging contributes to endothelial dysfunction, vessel stiffness, thickening, and impaired platelet function. These changes disrupt hemostatic processes and increase the risk of cardiovascular complications. Despite preventive strategies CVD remain a major public health challenge. Cellular aging, or senescence, affects all cell types, particularly endothelial cells and platelets. However, little research has compared the aging rates of different blood vessel types, such as arteries and veins. Given their distinct compositions and developmental origins, it is likely that their aging processes differ at molecular, cellular, and physiological levels.

Conditions

Interventions

TypeNameDescription
PROCEDUREGraft collectionSampling of superior venous and arterial grafts (internal mammary artery, great saphenous vein) after coronary artery bypass surgery.

Timeline

Start date
2025-07-17
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-08-14
Last updated
2025-08-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07122427. Inclusion in this directory is not an endorsement.